100 related articles for article (PubMed ID: 32238137)
1. The Association of
Ozdemir F; Dural E; Baskak NS; Kır Y; Baskak B; Suzen HS
Comb Chem High Throughput Screen; 2020; 23(10):1032-1040. PubMed ID: 32238137
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Concentration of Micro-RNA hsa-miR-370-3p and CYP2D6*4 on Equilibrium Concentration of Mirtazapine in Patients With Major Depressive Disorder.
Zastrozhin ; Smirnov ; Petukhov ; Pankratenko ; Zastrozhina ; Grishina ; Ryzhikova ; Bure ; Skryabin ; Vlasovskih ; Bryun ; Sychev
Psychopharmacol Bull; 2020 Jul; 50(3):58-75. PubMed ID: 32733112
[TBL] [Abstract][Full Text] [Related]
3. Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.
Zastrozhin MS; Efimova AV; Skryabin V; Smirnov VV; Petukhov AE; Pankratenko EP; Pozdniakov SA; Kaverina EV; Klepikov DA; Grishina EA; Ryzhikova KA; Bure IV; Bryun EA; Sychev DA
Psychopharmacol Bull; 2021 Nov; 51(4):87-104. PubMed ID: 34887601
[TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine.
Shinozaki M; Pierce J; Hayashi Y; Watanabe T; Sasaki T; Komahashi-Sasaki H; Akiyama K; Kato K; Inoue Y; Tsuchimine S; Yasui-Furukori N; Ozeki Y; Shimoda K
Pharmacopsychiatry; 2019 Sep; 52(5):237-244. PubMed ID: 31158907
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Jaquenoud Sirot E; Harenberg S; Vandel P; Lima CA; Perrenoud P; Kemmerling K; Zullino DF; Hilleret H; Crettol S; Jonzier-Perey M; Golay KP; Brocard M; Eap CB; Baumann P
J Clin Psychopharmacol; 2012 Oct; 32(5):622-9. PubMed ID: 22926595
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients.
Hayashi Y; Watanabe T; Aoki A; Ishiguro S; Ueda M; Akiyama K; Kato K; Inoue Y; Tsuchimine S; Yasui-Furukori N; Shimoda K
Pharmacopsychiatry; 2015 Nov; 48(7):279-85. PubMed ID: 26595747
[TBL] [Abstract][Full Text] [Related]
7. Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers.
Kirchheiner J; Henckel HB; Meineke I; Roots I; Brockmöller J
J Clin Psychopharmacol; 2004 Dec; 24(6):647-52. PubMed ID: 15538128
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Zastrozhin MS; Skryabin V; Smirnov V; Zastrozhina AK; Kaverina EV; Klepikov DA; Grishina EA; Ryzhikova KA; Bure IV; Bryun EA; Sychev DA
Psychopharmacol Bull; 2021 Mar; 51(2):31-42. PubMed ID: 34092821
[TBL] [Abstract][Full Text] [Related]
9. A Novel PCR-RFLP Method for Detection of POR*28 Polymorphism and its Genotype/Allele Frequencies in a Turkish Population.
Ozdemir F; Oz MD; Suzen HS
Curr Drug Metab; 2019; 20(10):845-851. PubMed ID: 31518218
[TBL] [Abstract][Full Text] [Related]
10. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
[TBL] [Abstract][Full Text] [Related]
11. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Tsai MH; Lin KM; Hsiao MC; Shen WW; Lu ML; Tang HS; Fang CK; Wu CS; Lu SC; Liu SC; Chen CY; Liu YL
Pharmacogenomics; 2010 Apr; 11(4):537-46. PubMed ID: 20350136
[TBL] [Abstract][Full Text] [Related]
13. Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder.
Zastrozhin MS; Skryabin VY; Smirnov VV; Grishina EA; Ryzhikova KA; Chumakov EM; Bryun EA; Sychev DA
Can J Physiol Pharmacol; 2019 Aug; 97(8):781-785. PubMed ID: 31100205
[TBL] [Abstract][Full Text] [Related]
14. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
van der Weide K; van der Weide J
J Clin Psychopharmacol; 2015 Jun; 35(3):228-36. PubMed ID: 25868121
[TBL] [Abstract][Full Text] [Related]
15. Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder.
Zastrozhin M; Skryabin V; Smirnov V; Zastrozhina A; Grishina E; Ryzhikova K; Bure I; Golovinskii P; Koporov S; Bryun E; Sychev D
Am J Ther; 2021 Jun; 29(1):e26-e33. PubMed ID: 34117140
[TBL] [Abstract][Full Text] [Related]
16. Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.
Borobia AM; Novalbos J; Guerra-López P; López-Rodríguez R; Tabares B; Rodríguez V; Abad-Santos F; Carcas AJ
Pharmacol Res; 2009 Jun; 59(6):393-8. PubMed ID: 19429471
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of single nucleotide polymorphisms and copy number variations in the CYP2D6 gene by multiplex polymerase chain reaction combined with capillary electrophoresis.
Liao HW; Tsai IL; Chen GY; Kuo CT; Wei MF; Hwang TJ; Chen WJ; Shen LJ; Kuo CH
Anal Chim Acta; 2013 Feb; 763():67-75. PubMed ID: 23340288
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
19. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population.
Serin A; Canan H; Alper B; Gulmen M
Forensic Sci Int; 2012 Oct; 222(1-3):332-4. PubMed ID: 22910059
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6 and CYP1A1 mutations in the Turkish population.
Aydin M; Hatirnaz O; Erensoy N; Ozbek U
Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
